foto

Dr. K. Fluiter

Position
Postdoc
Main activities
Research
Specialisation
Neurological disorders
Focus of research

Complement system

Antisense oligonucleotides

Neurological disease and trauma

Key publications
  • Aronica E, Fluiter K, Iyer A, Zurolo E, Vreijling J, van Vliet EA, Baayen JC, Gorter JA, Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. EUR J NEUROSCI 2010;31 (6):1100-1107 [PubMed]
  • Fluiter K, Mook ORF, Vreijling J, Langkjaer N, Højland T, Wengel J, Baas F, Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmer. MOL BIOSYST 2009;5 (8):838-843 [PubMed]
  • Budde BS, Namavar Y, Barth PG, Poll-The BT, Nürnberg G, Becker C, van Ruissen F, Weterman MAJ, Fluiter K, te Beek ET, Aronica E, van der Knaap MS, Höhne W, Toliat MR, Crow YJ, Steinlin M, Voit T, Roelens F, Brussel W, Brockmann K, Kyllerman M, Boltshauser E, Hammersen G, Willemsen M, Basel-Vanagaite L, Krägeloh-Mann I, de Vries LS, Sztriha L, Muntoni F, Ferrie CD, Battini R, Hennekam RCM, Grillo E, Beemer FA, Stoets LME, Wollnik B, Nürnberg P, Baas F, tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia. NAT GENET 2008;40 (9):1113-1118 [PubMed]
  • Fluiter K, ten Asbroek ALMA, de Wissel MB, Jakobs ME, Wissenbach M, Olsson H, Olsen O, Oerum H, Baas F, In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides. NUCLEIC ACIDS RES 2003;31 (3):953-962 [PubMed]
  • Fluiter K, ten Asbroek ALMA, van Groenigen M, Nooij M, Aalders MCG, Baas F, Tumor genotype-specific growth inhibition in vivo by antisense oligonucleotides against a polymorphic site of the large subunit of human RNA polymerase II. CANCER RES 2002;62 (7):2024-2028 [PubMed]
All Publications
Research programmes

Prof. dr. F. Baas (Genome analysis / Neurogenetics)

Other research related activities
  • Stock / Shareholder, Regenesance BV